Help us: Donate
Follow us on:
×

Update from CellAge

Share

Today is one of those days when we must deliver some bad news. Science is hard, particularly when it concerns the biology of aging, and things do not always go to plan. There are no guarantees that a project will succeed, and, quite simply, the more shots on goal we can get, the more chance that one of them will get through.

The news today is an example of when things do not work out as hoped, and it is with a heavy heart that we report this update from the CellAge team, which worked on a project that the Lifespan.io community helped to raise funds for.

We are writing to regretfully inform you that our time at CellAge has come to an end. In the coming weeks, we will be closing down the project and the company. While it breaks our hearts to do so, unfortunately this is the only way forward at this time. We have contacted our crowdfunding partner LEAF and have returned all of the unused crowdfunding funds – we believe that it will be put to good use in accordance with the LEAF mission.

For the last few years, the CellAge team has been working with the aim to develop synthetic promoters that would be able to specifically identify senescent cells. We have partnered with a number of different organisations designing R&D plans and developing methods to achieve this goal. While we had a number of operational hurdles along the way, we have made progress. We believe that it is possible to build on top of our work; therefore, we will share the results and details of our findings with the wider scientific community and the general public.

We would like to thank everyone for their support and enthusiasm around this project. While this specific project has reached its conclusion, we remain passionate about improving healthspan and the quality of human life. We will continue to put our energy and hard work towards this goal.

Sincerely,

CellAge Team

While we are disappointed to hear this news from the project team, we should never shy away from reporting the truth, no matter how unpleasant or unpalatable it might be. Aging research is hard, and developing a successful company to take a project to market is a huge challenge; this time it did not succeed, but the next time it might. We will keep on trying until we win.

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
  1. June 9, 2020

    Don´t give up :)

Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.